Gene ontology analysis highlighted autoantibodies targeting neuroactive ligands and receptors in AD, including anti-NPB antibody, as well as lipid metabolism-associated proteins in DLB, such as anti-ADGRF5 antibody (Figure 4). This evidence concerns the gene NPB and Alzheimer disease.